Healthcare's most valuable AI use cases rarely live in one dataset. Multimodal data integration—combining genomics, imaging, clinical notes, and wearables—is essential for precision oncology and early detection, yet many initiatives stall before production.

Precision oncology requires understanding both molecular drivers from genomic profiling and anatomical context from imaging. Early detection improves when inherited risk signals meet longitudinal wearables. And many of the “why” details—symptoms, response, rationale—still live in clinical notes.

Despite real progress in research, many multimodal initiatives stall before production—not because modeling is impossible, but because the data and operating model aren’t ready for clinical reality. The constraint isn’t model sophistication—it’s architecture: separate stacks per modality create fragile pipelines, duplicated governance, and costly data movement that breaks down under clinical deployment needs.

This post outlines a production-oriented lakehouse pattern for multimodal precision medicine: how to land each modality into governed Delta tables, create cross-modal features, and choose fusion strategies that survive real-world missing data.

Reference architecture

What “governed” means in practice

Throughout this post, “governed tables” means the data is secured and operationalized using Unity Catalog (or equivalent controls), including:

Data classification with governed tags: PHI/PII/28 CFR Part 202/StudyID/…

• Fine-grained access controls: catalog/schema/table/volume permissions, plus row/column-level controls where needed for PHI.
• Auditability: who accessed what, when (critical for regulated environments).
• Lineage: trace features and model inputs back to source datasets.
• Controlled sharing: consistent policy boundaries across teams and tools.

Reproducibility: versioning and time travel for datasets, CI/CD for pipelines/jobs, and MLflow for experiment and model version tracking.

This connects the technical architecture to business outcomes: fewer copies of sensitive data, reproducible analytics, and faster approvals for productionization.

Why multimodal is becoming the default

Single-modality models hit real limits in messy clinical settings. Imaging can be powerful, but many complex predictions benefit from molecular + longitudinal context. Genomics captures drivers, but not phenotype, environment, or day-to-day physiology. Notes and wearables add the “between the rows” signals that structured data often misses.

Volume reality matters: Databricks notes that roughly 80% of medical data is unstructured (for example, text and images). That’s why multimodal data integration has to handle unstructured notes and imaging at scale—not just structured EHR fields.

The practical takeaway: each modality is incomplete on its own. Multimodal systems work when they’re designed to:

1. Preserve modality-specific signal.
2. Stay robust when some inputs are missing.

Four fusion strategies (and when each survives production)

Fusion choice is rarely the only reason teams fail—but it often explains why pilots don’t translate: data is sparse, modalities arrive on different timelines, and governance requirements differ by data type.

1) Early fusion (Concatenate raw inputs before training.)

• Use when: small, tightly controlled cohorts with consistent modality availability.
• Tradeoff: scales poorly with high-dimensional genomics and large feature sets.

2) Intermediate fusion (Encode each modality separately, then merge hidden representations.)

• Use when: combining high-dimensional omics with lower-dimensional EHR/clinical features.
• Tradeoff: requires careful representation learning per modality and disciplined evaluation.

3) Late fusion (Train per-modality models, then combine predictions.)

• Use when: production rollouts where missing modalities are common.
• Benefit: degrades gracefully when one or more modalities are absent.

4) Attention-based fusion (Learn dynamic weighting across modalities and time.)

• Use when: time matters (wearables + longitudinal notes, repeated imaging) and interactions are complex.
• Tradeoff: harder to validate; requires careful controls to avoid spurious correlations.

Decision framework: match fusion to your deployment reality: modality availability patterns, dimensionality balance, and temporal dynamics.

The lakehouse as a multimodal substrate

A lakehouse approach reduces data movement across modalities: genomics tables, imaging metadata/features, text-derived entities, and streaming wearables can be governed and queried in one place—without rebuilding pipelines for each team.

Genomics processing (Glow + Delta)

Glow enables distributed genomics processing on Spark over common formats (e.g., VCF/BGEN/PLINK), with derived outputs stored as Delta tables that can be joined to clinical features.

Imaging similarity (derived features + Vector Search)

For imaging, the pattern is: (1) derive features/embeddings upstream (radiomics or deep model outputs), (2) store features as governed Delta tables (secured via Unity Catalog), and (3) use vector search for similarity queries (e.g., “find similar phenotypes within glioblastoma”).

This enables cohort discovery and retrospective comparisons without exporting data into separate systems.

Clinical notes (NLP to governed features)

Notes often contain missing context—timelines, symptoms, response, rationale. A practical approach is to extract entities + temporality into tables (med changes, symptoms, procedures, family history, timelines), keep raw text under strict governance (Unity Catalog + access controls), and join note-derived features back to imaging and omics for modeling and cohorting.

Wearables data (Lakeflow SDP for streaming + feature windows)

Wearables streams introduce operational requirements: schema evolution, late-arriving events, and continuous aggregation. Lakeflow Spark Declarative Pipelines (SDP) provides a robust ingestion-to-features pattern for streaming tables and materialized views. For readability, we refer to it as Lakeflow SDP below.

Syntax note: The pyspark.pipelines module (imported as dp) with @dp.table and @dp.materialized_view decorators follows current Databricks Lakeflow SDP Python semantics.

Why the unified storage + governance model matters

The operational win is coherence:

A common failure mode in cloud deployments is a “specialty store per modality” approach (for example: a FHIR store, a separate omics store, a separate imaging store, and a separate feature or vector store). In practice, that often means duplicated governance and brittle cross-store pipelines—making lineage, reproducibility, and multimodal joins much harder to operationalize.

• Reproducibility: ACID + time travel for consistent training sets and re-analysis.
• Auditability: access logs + lineage (what data produced what feature/model).
• Security: consistent policy boundaries across modalities (PHI-safe-by-design).
• Velocity: fewer handoffs and fewer data copies across teams.

This is what turns a multimodal prototype into something you can run, monitor, and defend in production.

Solving the missing modality problem

Real deployments confront incomplete data. Not all patients receive comprehensive genomic profiling. Imaging studies may be unavailable. Wearables exist only for enrolled populations. Missingness isn’t an edge case—it’s the default.

Production designs should assume sparsity and plan for it:

• Modality masking during training: remove inputs during development to simulate deployment reality.
• Sparse attention / modality-aware models: learn to use what’s available without over-relying on any single modality.
• Transfer learning strategies: train on richer cohorts and adapt to sparse clinical populations with careful validation.

Key insight: architectures that assume complete data tend to fail in production. Architectures designed for sparsity generalize.

Precision oncology pattern: from architecture to clinical workflow

A practical precision oncology pattern looks like this:

1. Genomic profiling -> governed molecular tables (Unity Catalog). Store variants, biomarkers, and annotations as queryable tables with lineage and controlled access.
2. Imaging-derived features -> similarity + cohorting. Index imaging feature vectors for “find similar cases” and phenotype–genotype correlations.
3. Notes-derived timelines -> eligibility + context. Extract temporally-aware entities to support trial screening and consistent longitudinal understanding.
4. Tumor board support layer (human-in-the-loop). Combine multimodal evidence into a consistent review view with provenance. The goal is not to automate decisions—it’s to reduce cycle time and improve consistency in evidence gathering.

Business impact: what changes when multimodal becomes operational

Market growth is one reason this matters—but the immediate driver is operational:

• Faster cohort assembly and re-analysis when new modalities arrive.
• Fewer data copies and fewer one-off pipelines.
• Shorter iteration cycles (weeks vs. months) for translational workflows.

Patient similarity analysis can also enable practical “N-of-1” reasoning by identifying historical matches with similar multimodal profiles—especially valuable in rare disease and heterogeneous oncology populations.

Get started: a pragmatic first 30 days

1. Pick one clinical decision (e.g., trial matching, risk stratification) and define success metrics.
2. Inventory modalities + missingness (who has genomics? imaging? longitudinal wearables?).
3. Stand up governed bronze/silver/gold tables secured via Unity Catalog.
4. Choose a fusion baseline that tolerates missingness (late fusion is often a safe start).
5. Operationalize: lineage, data quality checks, drift monitoring, reproducible training sets.
6. Plan validation: evaluation cohorts, bias checks, clinician workflow checkpoints.

Keywords: multimodal AI, precision medicine, genomics processing, medical imaging AI, healthcare data integration, fusion strategies, lakehouse architecture

High priority

Unity Catalog: https://www.databricks.com/product/unity-catalog

Healthcare & Life Sciences: https://www.databricks.com/solutions/industries/healthcare-and-life-sciences

Data Intelligence Platform for Healthcare and Life Sciences: https://www.databricks.com/resources/guide/data-intelligence-platform-for-healthcare-and-life-sciences

Medium priority

Mosaic AI Vector Search Documentation: https://docs.databricks.com/en/generative-ai/vector-search.html

Delta Lake on Databricks: https://www.databricks.com/product/delta-lake-on-databricks

Data Lakehouse (glossary): https://www.databricks.com/glossary/data-lakehouse

Additional related blogs

Unite your Patient's Data with Multi-Modal RAG: https://www.databricks.com/blog/unite-your-patients-data-multi-modal-rag

Transforming omics data management on the Databricks Data Intelligence Platform: https://www.databricks.com/blog/transforming-omics-data-management-databricks-data-intelligence-platform

Introducing Glow (Genomics): https://www.databricks.com/blog/2019/10/18/introducing-glow-an-open-source-toolkit-for-large-scale-genomic-analysis.html

Processing DICOM images at scale with databricks.pixels: https://www.databricks.com/blog/2023/03/16/building-lakehouse-healthcare-and-life-sciences-processing-dicom-images.html

Healthcare and Life Sciences Solution Accelerators: https://www.databricks.com/solutions/accelerators

Ready to move multimodal healthcare AI from pilots to production? Explore Databricks resources for HLS architectures, governance with Unity Catalog, and end-to-end implementation patterns.